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data set approach, with the dose distribution calculated with 
the treatment planning system used in that centre. 
Results: The gathering of IC and EPID datasets on a large 
variety of Elekta linacs went smoothly. For each linac/energy 
combination, a universal dataset was derived from similar 
linacs. This universal dataset was combined with only three 
measurements for each specific linac/energy combination: 
one IC measurement at the isocentre of a 20 cm thick 
phantom, and two EPID images, with and without the 
phantom in the beam. Preliminary validation results for 5 
linac/energy combinations and a set of square fields (3x3 to 
23x23 cm2) using the universal dataset, showed deviations of 
the dose at the iscocentre varying between -0.5% and +1.5%. 
Gamma analysis (3%/3mm) yielded values for the mean 
gamma, near-maximum gamma and gamma pass rate varying 
between 0.26-0.37, 0.67-1.04 and 96.5%-100.0%, 
respectively. These results are comparable to data obtained 
by a reconstruction from EPID measurements based on a full 
commissioning process in those centres. 
Conclusions: A generic set of EPID dosimetry model 
parameters has been derived for a variety of Elekta 
linac/energy combinations. Customizing the universal dataset 
in combination with 3 measurements instead of performing 
full commissioning decreases the amount of work needed to 
commission an EPID for dosimetry purposes by about 90% 
without a noticeable loss of accuracy. 
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Purpose/Objective: The goal of the retrospectively 
performed dose distribution simulations was to justify the 
concept of validating conformal versus intensity-modulated 
approach in the treatment of non-small cell lung cancer 
(NSCLC) patient. The insight into the difference between the 
actual (affected by respiratory motion) and planned dose 
distributions for both clinical target volume (CTV) and organs 
at risk (OARs) was provided. 
Materials and Methods: To test the influence of the 
respiratory motion on the dose distribution, for 10 patients 
representative for the spectrum of tumor sizes and locations, 
treated in free-breathing conditions (our standard 
institutional technique), 2 plans were prepared: with three-
dimensional conformal (3D-CRT) and sliding window intensity-
modulated radiation therapy (IMRT) techniques. For each of 
the field angles considered, the motion kernel (derived from 
the literature data) was generated to simulate tumor motion 
trajectories, with the largest amplitude in cranio-caudal 
direction of 4 mm, 6 mm and 8 mm repsectively. While the 
robotic platform MotionSim XY/4D with 2D diode array 
MapCHECK 2 (Sun Nuclear, USA) on it repeatedly cycled 
through the motion trajectory, radiation was delivered 
starting at a random point. The measurements’ results 
determined the agreement between the planned and 
measured doses within CTV and OARs. The evaluation of plan 
delivery was based on the Gamma Index (γ) with 3-mm 
criteria of distance to agreement (DTA) and 3% dose 
difference (ΔD).  
Results: No statistically significant differences were found 
between the motion patterns with the smallest amplitudes 
for CTV in 3DCRT plans. The differences were found for the 
8-mm amplitude when it was compared both to static 
conditions and 4-mm amplitude. For IMRT the significant 
differences between 0 mm vs. 6 mm, 0 mm vs. 8 mm and 4 
mm vs. 8 mm were found. According to the analysis 
performed for OARs, the motion impact on delivered vs. 
planned doses had less effect for esophagus and spinal cord. 
The only OARs for which the observed differences were 
comparable was heart.  
For maximal amplitudes of breathing trajectory below 4 mm 
the disagreement between planned and delivered dose 
distribution could be neglected. Whereas respiratory motion 
with amplitude above 5 mm, especially for IMRT, led to 
significant changes in delivered dose distribution. 
Conclusions: 3DCRT is safe in a greater range of respiratory 
movements amplitudes. For patients with large tumor sizes 
or due to inability of achieving proper 3DCRT dose 
distribution coming from tumor and OARs close proximity, the 
IMRT affords possibilities for further optimizing the 
therapeutic ratio. Statically planned IMRT dose distribution 
could lead to tumor underdosage due to interplay effect 
(intra-fractional motion with respect to the movement of 
MLC). It is therefore important to verify the amplitude of 
individual patient breathing motion trajectory. 
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Purpose/Objective: Craniospinal irradiation (CSI) using 
multiple isocentre intensity modulated radiation therapy 
(IMRT) allows for homogeneous dose distribution throughout 
the target and the dose distribution is conformed tightly 
around the target volume, reducing unnecessary dose to the 
organs-at-risk. The technique utilizes a combination of 
complicated field segments and there are sections of the 
treatment volume (junction) that are treated by fields from 
multiple isocenters. Small isocenter positional variations and 
dose changes in the junction regions may be unavoidable 
throughout the fractionated treatment. Dose sensitivity in 
the CSI IMRT junction region to positional and dose variations 
is tested using a diode array. 
Materials and Methods: Ten CSI patients were planned with a 
3-isocenter (cranial, upper and lower spine) IMRT technique 
using Pinnacle treatment planning system v9.2. The plans 
were prescribed to 36 Gy in 20 fractions. All beams were 
optimized simultaneously with a high weight placed on the 
target volume with lower weight placed on the other 
objectives. The isocenters were placed 25-27 cm away from 
each other. The IMRT plans were then recalculated and 
measured on a MapCHECK diode array placed in the 
upper/lower spine overlap region. ≥95% of measured to 
planned dose to the MapCHECK diodes with a γ-index <1 for 
3% dose difference and 3mm distance-to-agreement was 
deemed clinically acceptable.  
To test the sensitivity of junction region to positional and 
dose variations, the following changes were made to the plan 
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and recalculated plans were compared to the MapCHECK 
measured data as described in the previous section. 
1) 3mm shift in all translational directions to lower spine 
isocenter, 
2) ±3% and ±5% changes to overall number of monitor units 
(MU), and 
3) ±20MU change in a single beam (upper spine gantry 215°). 
Results: Table 1 shows the results of all the recalculated 
plans, with introduced changes as described in the above 
section, tested against the initial, correctly measured 
MapCHECK test. Figure 1 shows the graph representation of 
the deviations from the 3%/3mm γ-analysis (our centre's 
clinical standard test) for the plans with the changes 
introduced. The planned to measured dose compared using 
the γ-analysis is relatively insensitive to 3mm positional 
variations to lower spine isocenter as only a slightly lower 
than the initial percent pass rates are observed. This 
indicates that 3mm positional variations in fields do not 
cause large changes in the dose distribution due to high 
segment modulation. However, the 3%/3mm γ-analysis was 
more sensitive dose changes as overall ±3% in MU and changes 
of ±20MU in one field shows a greater change than positional 
variations. 
 
 
 
 
Conclusions: For multiple isocenter CSI, a small variation in 
isocenter position is unavoidable throughout the fractionated 
treatment. The results in this study indicate that 3mm 
positional changes in one isocenter with respect to the other 
may not cause detrimental changes in dose distribution. 
However, the measurements were sensitive to changes in 
overall dose and in a single field dose.  
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Purpose/Objective: Mobius3D (Mobius Medical Systems, 
Houston, TX, USA) is QA software performing 3D treatment 
plan verification. Mobius3D (M3D) uses a collapsed-cone 
algorithm for dose calculations which makes it suitable for a 
wide range of treatment technics. 
After sending the CTdataset, RTplan, RTstructure and RTdose 
from the treatment planning system (TPS) the system starts 
calculating automatically. Results are available in PDF and 
include 3D gamma evaluation, dose volume histogram (DVH) 
and region of interest (ROI) overview. 
In our clinic standard pretreatment QA is performed with a 
2D ionization chamber array placed in a phantom. Gamma 
evaluation of the composite dose is performed in one plane. 
The minimum pass rate for a treatment plan verification to 
be acceptable is 95%. 
The treatment plan verification with Mobius3D is compared 
with the standard pretreatment QA. 
Goal is to obtain a more efficient procedure of verifying 
VMAT lung SBRT plans without compromising on accuracy. 
 
Materials and Methods: Twenty five VMAT lung Stereotactic 
Body Radiation Therapy (SBRT) plans were randomly selected 
in the TPS (Pinnacle v9.2, Philips Healthcare, Best, The 
Netherlands). The absolute pretreatment measurements were 
performed with a 2D ionization chamber array (Octavius II, 
PTW, Freiburg, Germany) in a phantom and compared with 
the planar dose of the recomputed treatment plan on the 
scanned phantom. The detector array has a density override, 
as recommended by the manufacturer. If necessary the 
isocenter is moved to achieve a high dose area in the 
detector array plane. The gamma evaluation of the 
measurements are performed with in-house developed 
software. 
The CTdataset, RTplan, RTstructure and RTdose of both the 
original plan and the recalculated phantom plan are send to 
Mobius3D. 
The stereotactic approach requires a tight margin, the 
distance to agreement criterion is set to 2 mm. The dose 
difference is set to 3% if a homogeneous phantom is uses and 
5% for calculations on a heterogeneous CT set. In all cases, 
the gamma evaluation dose threshold is set to 30%. 
The gamma pass rates of the three situations are evaluated 
as well as the difference between the mean internal target 
volume (ITV) dose calculated by the TPS and by Mobius3D. 
Results:  
The gamma pass distribution per pass rate interval for 25 
treatment plan is shown in the figure. 
